Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bexarotene in Acute Myeloid Leukemia
NCT00615784Phase 2Terminated
- Sponsor
- Abramson Cancer Center
- Start
- May 2010
- Primary completion
- Oct 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of bexarotene in acute myeloid leukemia (AML), sponsored by Abramson Cancer Center. Started May 2010; status: terminated.
02
Drugs
bexarotene
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT00615784.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00615784.